Aromatic Beta-Blocker Atenolol from Japan
Atenolol is a synthetic aromatic beta-blocker drug used primarily for treating hypertension and angina. It falls under HTS 2942.00.05.00 as an aromatic organic compound classified as a drug, distinct from standard pharmaceuticals in Chapters 29 or 30. This code applies to specific aromatic or modified aromatic drugs not covered elsewhere.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.628.5%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Verify drug status with FDA registration and provide Certificate of Analysis confirming aromatic structure
• Ensure compliance with DEA scheduling if applicable; avoid misclassification as Chapter 30 finished dosage forms
• Include stability data for transport as per Chapter 29 note (f) to prevent reclassification